[ Price : $8.95]
Members of FDAs Oncologic Drugs Advisory Committee vote not to recommend expanding use of GlaxoSmithKlines Avodart (dutasteride) a...[ Price : $8.95]
FDA medical reviewers ask the Oncologic Drugs Advisory Committee whether a proposed indication for AstraZenecas vandetanib should ...[ Price : $8.95]
FDA clears an X-spine 510(k) for the AXLE Interspinous Fusion System, intended for use in providing spinal stability for lumbar fu...[ Price : $8.95]
Optimer Pharmaceuticals files an NDA for fidaxomicin, indicated for treating patients with clostridium difficile infection.[ Price : $8.95]
A New England Journal of Medicine report says FDA and industry each should be responsible for the credibility of drug and device i...[ Price : $8.95]
Federal Register Notice: FDA plans to expand its Conference Cooperative Agreement Program, awarded to the Brookings Institution to...[ Price : $8.95]
A new study reported online in the Journal of the American Medical Association finds high levels of variability and inconsistency ...[ Price : $8.95]
Federal Register Direct final rule: FDA amends it s regulations to include tobacco products where appropriate.